Adelia Therapeutics Inc.

Adelia Therapeutics was founded in 2020 by a longtime organizer, activist and educator in the psychedelic movement and a world renowned medicinal chemist and inventor with proven success in bringing psychedelics to market. The company's goal is to develop psychedelics with improved dosing efficacy and therapeutic indices to address unmet medical needs in CNS disorders.